Research News & Studies

Topics

<< < (3/290) > >>

[1] Lenacapavir capsid inhibitor (GS-6207) - CAPELLA trial

[2] Mosaico & Imbokodo HIV vaccine - HIV Vaccine Fails

[3] Daily PrEP is safe for the kidneys

[4] $1.3 Million Grant to Develop Interventions for Black Smokers With HIV

[5] State of HIV Cure Research as 2022 Comes to an End

[6] MSD/Merck’s once-weekly phase 2 study stopped - NNRTI MK-8507

[7] HIV Time to Viral Rebound After Interruption of Modern ART. (ACTG) A5345

[8] Virologic Failure Following Low-level Viremia - Results Multicenter Cohort

[9] Broadly Neutralizing Antibodies - Broad in Theory, Narrow in Reality

Navigation

[0] Up one level

[#] Next page

[*] Previous page